New drug candidates reverse drug resistance in multiple myeloma in preclinical models
In an article published online October 12, 2018 by Leukemia, Medical University of South Carolina investigators report that a new compound enhances the efficacy of proteasome inhibitors (PIs), the standard-of-care for the ...
Oct 29, 2018
0
50